• Alopecia
• Acniform eruptions
• Benign tumors
• Bullous diseases
• Dermoscopy
• Nevi, melanoma
• Nonmelanoma cancer
• Psoriasis and others
• Stds
• Vascular tumors
• Vulvar disease

• Herpes simplex
• Genital Herpes Simplex Introduction STD
• Genital Herpes Simplex Risk factors and Rate of Transmission
• Previous HSV type 1 infection
• Genital Herpes Simplex Primary and Recurrent Infections
• Genital Herpes Simplex Signs and Symptoms
• Genital Herpes Simplex Latency and Reactivation STD
• Genital Herpes Simplex Recurrent Infection STD
• Genital Herpes Simplex Frequency of Recurrence
• Genital Herpes Simplex Anatomic Site
• Genital Herpes Simplex Asymptomatic transmission
• Genital Herpes Simplex Prevention
• Genital Herpes Simplex Laboratory diagnosis
• Genital Herpes Simplex Serology
• Genital Herpes Simplex Testing Pregnant Women
• Genital Herpes Simplex Monogamous Couples
• Genital Herpes Simplex STD Treatment
• Genital Herpes Simplex Daily Treatment Suppressive Therapy
• Genital Herpes Simplex During Pregnancy
• Warts (HPV infection)
• Genital Warts HPV Introduction and Causes STD
• Genital Warts HPV Screening Tests
• Genital Warts HPV Interpretation of Test Results
• Genital Warts HPV The HPV DNA Test
• Genital Warts HPV Lesion and Location
• Genital Warts HPV Lesion Types STD
• Genital Warts HPV Subclinical Lesions
• Genital Warts HPV Bowenoid Papulosis STD
• Genital Warts HPV Clinical Evaluation STD
• Genital Warts HPV Differential diagnosis
• Genital Warts HPV Treatment STD
• Genital Warts HPV Treatment Approach to Therapy
• Molluscum Contagiosum
• Molluscum Contagiosum STD Introduction
• Molluscum Contagiosum Clinical manifestations
• Molluscum Contagiosum Diagnosis
• Molluscum Contagiosum Treatment
• Syphilis
• Syphilis Epidemiology STD
• Syphilis Treponema Pallidum
• Syphilis Causes STD
• Incubating Syphilis
• Secondary Syphilis STD
• Syphilis Latency
• Congenital Syphilis
• Early Congenital Syphilis
• Late Congenital Syphilis
• Syphilis Laboratory Diagnosis
• Syphilis Serologic Tests
• Syphilis Nontreponemal Reaginic Tests
• Syphilis Specific Treponemal Tests
• False-Positive Serologic Test for Syphilis
• Syphilis Treatment STD
• Chancroid
• Chancroid STD Introduction
• Chancroid Clinical presentation
• Chancroid Diagnosis
• Chancroid Treatment STD
• Chancroid Syndromic management
• Lymphogranuloma venereum
• Lymphogranuloma Venereum STD Introduction
• Lymphogranuloma Venereum Clinical features
• Lymphogranuloma Venereum Laboratory diagnosis
• Lymphogranuloma Venereum Treatment
• Donovanosis (granuloma inguinale)
• Donovanosis Granuloma Inguinale STD Introduction
• Donovanosis Granuloma Inguinale STD Clinical apperances
• Donovanosis Granuloma Inguinale STD Diagnostic tests
• Donovanosis Granuloma Inguinale STD Treatment

Genital Herpes Simplex Daily Treatment Suppressive Therapy

Daily suppressive therapy

The decision to initiate continuous suppressive therapy is subjective and is based on the frequency and severity of recurrences and psychosocial factors. Continuous daily suppressive therapy significantly reduces, but not completely suppress, the amount of asymptomatic shedding, clinical outbreaks and rate of transmission. Daily suppressive therapy reduces the frequency of genital herpes recurrences by 75% among patients who have frequent recurrences (i.e., six or more recurrences per year). Safety and efficacy have been documented among patients receiving daily therapy for years. Suppressive therapy has not been associated with emergence of clinically significant acyclovir resistance among immunocompetent patients. After 1 year of continuous suppressive therapy, discontinuation of therapy should be discussed with the patient to assess the patient's psychological adjustment to genital herpes and rate of recurrent episodes, as the frequency of recurrences decreases over time in many patients.